← Leaderboards
Laura Jacobsen
University Of Florida
$1,431,316
Attributed
$1,431,316
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $931.9K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,431,316 · 2
By mechanism
R01$812,943 · 1
K08$618,373 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Wei-Jun Qian$13,199,384
- Julie A. Johnson$37,866,281
- Edward Phelps$2,830,352
- Rhonda M Cooper-Dehoff$672,170
- Cuong Q Nguyen$5,076,541
Others in their field
Other Emerging Leaders on “Immunophenotyping”
- Giacomo Vacca · Kinetic River Corporation$4,262,086
- Cecilia Larocca · Brigham And Women'S Hospital$3,995,479
- Charles Andrew Stewart · Cartesian Therapeutics, Inc.$3,974,685
- Martin Alfons Gengenbacher · Hackensack University Medical Center$3,827,753
- Niccolo Terrando · Duke University$3,352,935
- Esteban Braggio · Mayo Clinic Rochester$3,103,066
Research focus
ImmunophenotypingInsulin Dependent Diabetes Mellitus OnsetFundingImmune ToleranceImmunotherapy TrialsInsulin-Dependent Diabetes MellitusDoseFrequenciesGlycosylated Hemoglobin AImmuneImmunotherapyBiological MarkersAntithymoglobulinClinical TrialsClinical EfficacyC-PeptideEnrollmentExhaustFutureGenomicsCell PhysiologyBeta CellClinical Trials DesignIn Vivo
Grant awards (6)
Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetes$812,943
R01 · FY2025 · DK · contact PI
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes$118,908
K08 · FY2025 · DK · contact PI
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes$122,909
K08 · FY2024 · DK · contact PI
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes$129,370
K08 · FY2023 · DK · contact PI
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes$129,370
K08 · FY2022 · DK · contact PI
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes$117,816
K08 · FY2021 · DK · contact PI